EDIT Message Board Post 9191032 | Editas Medicine Inc.
home / stock / edit / edit message board
mmarcus25
(investorshub)
Posted on: Nov/10/2020 21:31:03
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159412463
SITC poster https://www.editasmedicine.com/wp-content/uploads/2020/11/$EDIT-201_E
News, Short Squeeze, Breakout and More Instantly...
-
All patients treated in the RUBY trial are free of vaso-occlusive events post- renizgamglogene autogedtemcel (reni-cel) infusion Patients had early normalization of total hemoglobin with a mean within the normal range at >14 g/dL and rapid and sustained improvements in fetal ...
-
All patients treated in the EdiTHAL trial maintained hemoglobin levels above the transfusion threshold and are transfusion-free post- renizgamglogene autogedtemcel (reni-cel) infusion Reni-cel was well-tolerated and demonstrated a safety profile consistent with myeloablative con...